Kevin Horton
Internal Medicine · San Antonio, TXNPI 1710962972
Payments from drug & device makers
Across 79 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$385
- Amarin Pharma, Inc.$289
- Si-bone, Inc.$160
- Teva Pharmaceuticals USA, Inc.$125
- Exactech, Inc.$107
- Johnson & Johnson$85
- plus $567 from 17 others
What the payments were for
- Food & beverage$1,719100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 24 | $385 |
| Amarin Pharma, Inc. | 11 | $289 |
| Si-bone, Inc. | 3 | $160 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Exactech, Inc. | 1 | $107 |
| Johnson & Johnson | 4 | $85 |
| Boehringer Ingelheim | 6 | $85 |
| Novo Nordisk | 3 | $58 |
| Almatica Pharma LLC | 3 | $52 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Novartis | 3 | $39 |
| Pfizer | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $36 |
| Amgen | 2 | $33 |
| Bayer | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Esperion Therapeutics, Inc. | 2 | $25 |
| Eisai Inc. | 1 | $24 |
| AstraZeneca | 1 | $21 |
| GSK | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$130
- AJOVY$125
- iFuse Implant$125
- EQUINOXE$107
How this compares
$1,719 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 115 | $119,663 |
| OzempicSemaglutide | 65 | $67,742 |
| JardianceEmpagliflozin | 34 | $46,005 |
| TrulicityDulaglutide | 32 | $38,700 |
| EliquisApixaban | 26 | $27,781 |
| XareltoRivaroxaban | 16 | $25,101 |
| FarxigaDapagliflozin Propanediol | 22 | $24,519 |
| KerendiaFinerenone | 11 | $14,124 |
| JanuviaSitagliptin Phosphate | 12 | $9,867 |
| BelsomraSuvorexant | 14 | $5,907 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,829 |
| PaxlovidNirmatrelvir/Ritonavir | 19 | $2,859 |
| Levothyroxine Sodium | 197 | $2,581 |
| Ipratropium Bromide | 72 | $1,994 |
| Atorvastatin Calcium | 209 | $1,988 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $385 | $158,363147 claims |
| Novo NordiskOzempic | $58 | $67,74265 claims |
| Boehringer IngelheimJardiance | $85 | $46,00534 claims |
| PfizerEliquis, Paxlovid | $36 | $30,64045 claims |
| Johnson & JohnsonXarelto | $85 | $25,10116 claims |
| AstraZenecaFarxiga | $21 | $24,51922 claims |
| BayerKerendia | $32 | $14,12411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.